151 related articles for article (PubMed ID: 6535125)
1. [Pulmonary volume and flows in asthmatic children in therapy with prompt and delayed-action theophylline: preliminary report].
Fiocchi A; Berardinelli P; Di Donna C; Arensi D; Riva E
Pediatr Med Chir; 1984; 6(5):641-4. PubMed ID: 6535125
[TBL] [Abstract][Full Text] [Related]
2. Theophylline administration in children with asthma: optimal pulmonary function and possible tolerance to chronic administration.
Katz RM; Rachelefsky GS; Siegel SC; Mickey R
Ann Allergy; 1983 Jan; 50(1):23-6. PubMed ID: 6849515
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness and tolerance of the treatment of infantile bronchial asthma with soluble and delayed-action theophylline].
Navarro M; Durán JA; Delgado JA; Serrano JS; González Hachero J
An Esp Pediatr; 1987 Mar; 26(3):171-7. PubMed ID: 3579056
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
Menendez R; Kelly HW; Howick J; McWilliams BC
Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
[TBL] [Abstract][Full Text] [Related]
5. [Monitoring long-term therapy with theophylline preparations in children with asthma].
Lindemann H; Bauer J; Schwandt HJ
Monatsschr Kinderheilkd; 1985 Feb; 133(2):106-10. PubMed ID: 3920513
[TBL] [Abstract][Full Text] [Related]
6. [Sustained-action oral theophylline in the asthmatic child. Clinical, pharmacokinetic and respiratory function studies].
Baculard A; Morgant G; Gaultier C; Boule M; Tournier G
Rev Fr Mal Respir; 1983; 11(6):833-46. PubMed ID: 6669796
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous use of rapidly absorbed and sustained release theophylline preparations in children.
Hein EW; Domson JF; Sheen A; Buffone GJ; Sly RM
Ann Allergy; 1979 Oct; 43(4):217-9. PubMed ID: 555597
[TBL] [Abstract][Full Text] [Related]
8. Plasma theophylline concentrations in asthmatic children receiving a twice daily theophylline preparation.
Teo J; Lee HS; Teo PC
Singapore Med J; 1986 Jun; 27(3):210-3. PubMed ID: 3764456
[No Abstract] [Full Text] [Related]
9. [Serum pyridoxal concentration in children during theophylline therapy for bronchial asthma].
Tanaka I; Hiraga Y; Inaba J; Fujino M; Kobayashi K
Arerugi; 1994 Sep; 43(9):1172-8. PubMed ID: 7802601
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic properties of sustained-release theophylline (Theolair-SR) in relation to timing of doses after low-fat meals.
Welsh PW; O'Connell EJ; Sachs MI; Moyer TP; Wick KA; Harrison LI; McCarville SE; Kvam DC
Ann Allergy; 1989 May; 62(5):396-400. PubMed ID: 2719348
[TBL] [Abstract][Full Text] [Related]
12. [Slow-release theophyllines: serum and saliva levels in asthmatic children].
Souto Martínez I; Duque Hernández J; Galván Tudela L; Alvarez Sanz E; Díaz Gómez MI
An Esp Pediatr; 1988 Jun; 28(6):513-6. PubMed ID: 3195854
[TBL] [Abstract][Full Text] [Related]
13. [Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation].
Longo G; Poli F; Strinati R; Longo F
Pediatr Med Chir; 1984; 6(5):645-9. PubMed ID: 6535126
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
Cantani A; Businco E; Businco L; Solano A; Calabretta C
Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
[TBL] [Abstract][Full Text] [Related]
15. [The usefulness of the bayesian method for the prediction of plasma theophylline levels in asthmatic children during RTC therapy by the sustained preparation of theophylline].
Okabe T; Hida M; Maruyama K; Kohgo T; Shibuya M; Ohashi A
Arerugi; 1994 Apr; 43(4):563-70. PubMed ID: 8031252
[TBL] [Abstract][Full Text] [Related]
16. Lung function improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level +/- 10 mg/l) compared to one week placebo.
Van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML
Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):638-42. PubMed ID: 3025113
[TBL] [Abstract][Full Text] [Related]
17. [Monitoring of three delayed-release preparations of theophylline in the plasma of children: pharmacokinetic parameters and therapeutic significance].
Domínguez Granados R; Pita Calandre E; Girón Caro F; Gómez Rubio M; Molina Font JA
An Esp Pediatr; 1987 Nov; 27(5):357-61. PubMed ID: 3439657
[TBL] [Abstract][Full Text] [Related]
18. [Serum theophylline levels after oral administration in a group of asthmatic children].
Escorihuela R; Llerena P; Royo F; Lillo Lillo M; de la Morena E; Borges Domingo T; López-Linares M
An Esp Pediatr; 1982 Dec; 17(6):461-5. PubMed ID: 7183217
[TBL] [Abstract][Full Text] [Related]
19. The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
Schaefers M; Richter O; Reinhardt D; Becker B
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):406-15. PubMed ID: 6490223
[TBL] [Abstract][Full Text] [Related]
20. Symptoms and peak expiratory flow rate: response to a slow release theophylline preparation.
Ho TF; Ngiam TE; Koh PK
Singapore Med J; 1983 Oct; 24(5):280-4. PubMed ID: 6669991
[No Abstract] [Full Text] [Related]
[Next] [New Search]
